Supplemental material
Open access
715
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET
Reyna KV LimAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Matthew BuschmanAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Alisher KhasanovAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Arthur LedesmaAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Jiang ChenAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Thanhtruc NguyenAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Xiao GuoAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Lingna LiAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Jonathan HuangAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Jin NiuAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Lisa KerwinAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Rengang WangAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Yurong GuoAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Tong ZhuAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Gunnar KaufmannAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Yanliang ZhangAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Heyou ZhouAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
, Henry JiAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USAView further author information
& Yanwen FuAntibody Discovery & Technology, Sorrento Therapeutics, Inc, San Diego, CA, USACorrespondence[email protected]
View further author information
show allView further author information
Pages 1137-1149
|
Received 24 Aug 2023, Accepted 05 Dec 2023, Published online: 11 Dec 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.